Kriya Therapeutics, Inc.
Clinical trials sponsored by Kriya Therapeutics, Inc., explained in plain language.
-
Can a single gene therapy injection reverse fatty liver disease?
Disease control Not yet recruitingThis trial tests an experimental gene therapy called VV-14303 for people with metabolic dysfunction-associated steatohepatitis (MASH), a serious liver condition linked to obesity and diabetes. The therapy uses a harmless virus to deliver a protein (FGF21) that may improve liver h…
Phase: PHASE1, PHASE2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Gene therapy shot around the eye aims to reduce bulging in thyroid eye disease
Disease control Not yet recruitingThis study tests a new gene therapy called VV-14305, given as an injection around the eye, for people with moderate to severe thyroid eye disease. The trial will include 110 adults and is split into two parts: first to check safety, then to compare the treatment against a sham in…
Phase: PHASE1, PHASE2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC